Ultragenyx

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$25.75
Previous Close
$25.80
Day Range
$24.87-$25.82
52W Range
$18.29-$42.37
Market Cap
$2.6B
Shares Short
13M

Financials

See more
Revenue (12 Mos)
$670M
Revenue Growth (YoY)
-2.2%
Gross Profit (12 Mos)
-$188M
Diluted EPS
-$6.10

News

See more

Yahoo Finance • 16 days ago

Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial

Yahoo Finance • last month

ULTRAGENYX URGENT DEADLINE: Bragar Eagel & Squire, P.C. Reminds Ultragenyx (NASDAQ:RARE) Investors of the April 6th Lead Plaintiff Deadline and Urges Investors to Contact the Firm

Yahoo Finance • last month

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

Yahoo Finance • last month

RARE DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARE

About

CEO
Dr. Emil D. Kakkis M.D., Ph.D.
CFO
Mr. Howard Horn
Address
60 Leveroni Court, Novato, CA, United States, 94949
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
1,371